What is the CLL B-Lymphocyte?
- 1 January 1996
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 22 (sup2) , 13-39
- https://doi.org/10.3109/10428199609102700
Abstract
(1996). What is the CLL B-Lymphocyte? Leukemia & Lymphoma: Vol. 22, No. sup2, pp. 13-39.This publication has 58 references indexed in Scilit:
- Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals.Journal of Clinical Investigation, 1995
- Idiotypic DNA Vaccines Against B‐cell LymphomaImmunological Reviews, 1995
- Failure of B Cells of Chronic Lymphocytic Leukemia in Presenting Soluble and AlloantigensClinical Immunology and Immunopathology, 1995
- The pathogenesis of chronic lymphocytic leukemia: analysis of the antibody repertoireImmunology Today, 1994
- CD38 signaling by agonistic monoclonal antibody prevents apoptosis of human germinal center B cellsEuropean Journal of Immunology, 1994
- Lack of extensive mutations in the VH5 genes used in common B cell chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1993
- Prospects for the Treatment of B Cell Tumors Using Idiotypic VaccinationInternational Reviews of Immunology, 1989
- Production of autoantibodies by CD5-expressing B lymphocytes from patients with chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1989
- Interleukin 4 counteracts the interleukin 2-induced proliferation of monoclonal B cells.The Journal of Experimental Medicine, 1988
- Peritoneal Ly‐1 B cells: Genetic control, autoantibody production, increased lambda light chain expressionEuropean Journal of Immunology, 1986